Featured

Acurx Pharmaceuticals Shares Jump 10% After Reaching Phase 2b Milestone Evaluating Ibezapolstat To Treat C. difficle (NASDAQ: ACXP)

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Send this to a friend